• Home
  • Search Results
  • Pantothenate and pantetheine antagonize the antitubercular activity of pyrazinamide.

Pantothenate and pantetheine antagonize the antitubercular activity of pyrazinamide.

Antimicrobial agents and chemotherapy (2014-09-24)
Nicholas A Dillon, Nicholas D Peterson, Brandon C Rosen, Anthony D Baughn
ABSTRACT

Pyrazinamide (PZA) is a first-line tuberculosis drug that inhibits the growth of Mycobacterium tuberculosis via an as yet undefined mechanism. An M. tuberculosis laboratory strain that was auxotrophic for pantothenate was found to be insensitive to PZA and to the active form, pyrazinoic acid (POA). To determine whether this phenotype was strain or condition specific, the effect of pantothenate supplementation on PZA activity was assessed using prototrophic strains of M. tuberculosis. It was found that pantothenate and other β-alanine-containing metabolites abolished PZA and POA susceptibility, suggesting that POA might selectively target pantothenate synthesis. However, when the pantothenate-auxotrophic strain was cultivated using a subantagonistic concentration of pantetheine in lieu of pantothenate, susceptibility to PZA and POA was restored. In addition, we found that β-alanine could not antagonize PZA and POA activity against the pantothenate-auxotrophic strain, indicating that the antagonism is specific to pantothenate. Moreover, pantothenate-mediated antagonism was observed for structurally related compounds, including n-propyl pyrazinoate, 5-chloropyrazinamide, and nicotinamide, but not for nicotinic acid or isoniazid. Taken together, these data demonstrate that while pantothenate can interfere with the action of PZA, pantothenate synthesis is not directly targeted by PZA. Our findings suggest that targeting of pantothenate synthesis has the potential to enhance PZA efficacy and possibly to restore PZA susceptibility in isolates with panD-linked resistance.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Glycine, suitable for electrophoresis, ≥99%
Sigma-Aldrich
Glycine, ReagentPlus®, ≥99% (HPLC)
Sigma-Aldrich
Nicotinamide, BioReagent, suitable for cell culture, suitable for insect cell culture
Sigma-Aldrich
Glycine, BioUltra, for molecular biology, ≥99.0% (NT)
Sigma-Aldrich
Nicotinamide, ≥99.5% (HPLC)
Sigma-Aldrich
Nicotinic acid, ≥98%
Supelco
Niacinamide, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Glycine, ACS reagent, ≥98.5%
Sigma-Aldrich
Glycine, from non-animal source, meets EP, JP, USP testing specifications, suitable for cell culture, ≥98.5%
Sigma-Aldrich
Nicotinamide, ≥98% (HPLC), powder
SAFC
Glycine
Supelco
Niacin (Nicotinic Acid), Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Nicotinic acid, ≥99.5% (HPLC)
Sigma-Aldrich
Nicotinic acid, BioReagent, suitable for cell culture, suitable for insect cell culture, suitable for plant cell culture, ≥98%
Sigma-Aldrich
Niacinamide, meets USP testing specifications
Supelco
Glycine, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Glycine, BioXtra, ≥99% (titration)
Supelco
Nicotinic acid, analytical standard
USP
Niacin, United States Pharmacopeia (USP) Reference Standard
USP
Glycine, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
Nicotinamide, ≥98.5% (HPLC)
USP
Niacinamide, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
Glycine, 99%, FCC
Nicotinamide, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
Nicotinic acid, meets USP testing specifications
Glycine, European Pharmacopoeia (EP) Reference Standard
Nicotinic acid, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
Glycine, tested according to Ph. Eur.